Table 1.

Effect of streptozotocin-induced diabetes and myriocin treatment (for 7 days) on body weight, fasting serum glucose, insulin, and FFA levels.

	C	M	D	D + M
Body weight (g)	305,8 ± 18,00	246,0 ± 16,93*	215,2 ± 10,85*	188,2 ± 12,09∗†
Glucose level (mg/dL)	102,8 ± 5,93	92,8 ± 6,34	536,0 ± 16,26*	254,6 ± 24,80∗†
Insulin level (µU/mL)	4,5 ± 0,81	4,8 ± 0,64	nd	nd
FFA level (µmol/L)	88,6 ± 10,48	95,8 ± 8,89	150,4 ± 17,30*	156,8 ± 12,4*

C: control group; M: group treated with myriocin; D: streptozotocin-induced diabetic group; D + M: streptozotocin-induced diabetic group treated with myriocin; FFA: free fatty acids. Results are based on 8 independent preparations for each experimental treatment (means ± SE).

*P < 0,01 compared with C group. ^† P < 0,01 compared with D group. nd: not detected.